Liv-333 Violates Liv.52 Trademark, Delhi HC Slaps Rs 20 Lakh Damages on Rajasthan Aushdhalaya for Infringing Himalaya's Brand Farhat Nasim10 July 2025 6:58 PM ISTNew Delhi: The Delhi High Court has upheld a commercial court's judgment restraining Rajasthan Aushdhalaya Pvt Ltd from using "Liv-333" as a...
CDSCO Panel Recommends Phase IV Trial for Acne FDC Gel by Precise Biopharma Parthika Patel9 July 2025 11:37 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...
Email From 'Chairman' Costs Pharma Company Rs 1.9 Crore in Cyber Fraud Farhat Nasim8 July 2025 5:54 PM ISTBengaluru: A meticulously executed email spoofing attack has led to a massive financial loss for a pharmaceutical company. The North Division Cyber...
Madras HC Flags Licensing Gap, Says Ayurvedic Imports Must Meet Indian Drug Standards Farhat Nasim7 July 2025 7:42 PM ISTChennai: Observing that "it is necessary for the rule-making authority to modify existing rules, prescribe standards and prepare appropriate forms in...
Govt Panel Proposes Braille Cards, Voice-Enabled QR Codes on Medicine Packs to Aid Visually Impaired Farhat Nasim6 July 2025 11:30 AM ISTNew Delhi: In a move aimed at improving accessibility for the visually impaired, the Drugs Consultative Committee (DCC) has recommended placing the...
Govt Panel Makes This Approval Mandatory For New Drug Licenses Farhat Nasim5 July 2025 4:44 PM ISTNew Delhi: Raising serious regulatory concerns, the apex statutory body under the Central Drugs Standard Control Organisation (CDSCO), the Drugs...
CBI Cracks Down on PCI Chief Montu Patel in College Bribery Scandal Farhat Nasim4 July 2025 2:00 PM ISTAhmedabad: The Chief of the Pharmacy Council of India (PCI), Dr Montu Kumar Patel, has come under the scanner of the Central Bureau of Investigation...
Delhi HC Flags Off-Label Use of Diabetes Drugs for Weight Loss, Seeks CDSCO Report Farhat Nasim3 July 2025 9:27 PM ISTNew Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)...
Delhi HC Rejects Modi-Mundipharma's Monopoly Claim Over 'CONTIN', Allows Limited Relief Farhat Nasim2 July 2025 4:45 PM ISTNew Delhi: Noting that a pharma company cannot claim monopoly over descriptive elements like "FE" and "CONTIN" used generically in the industry, the...
DCC Recommends Licensing, Labelling Restrictions on Anti-TB Drugs to Curb Private Market Misuse Farhat Nasim1 July 2025 11:07 PM ISTNew Delhi: In a move to curb potential misuse of critical tuberculosis medications, the Drugs Consultative Committee (DCC) has recommended that...
After Much Tussle, Torrent Pharma Clinches JB Chemicals Deal at Rupees 25,689 Crore Valuation Farhat Nasim30 Jun 2025 3:07 PM ISTMumbai: The JB Pharma divestment saga has finally seen its fate as Torrent Pharmaceuticals Limited and global investment firm KKR announced that...
Pharma Firms To Face Periodic Inspection As HC Flags Effluent Risks Farhat Nasim29 Jun 2025 8:00 PM ISTSikkim: The High Court of Sikkim has disposed of a Public Interest Litigation (PIL) concerning the unauthorised release of effluents and extraction of...
